JWA Sensitizes P-Glycoprotein-Mediated Drug-Resistant Choriocarcinoma Cells to Etoposide VIA JNK and Mitochondrial-Associated Signal Pathway

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Toxicology and Environmental Health, Part A

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/15287390902841649PMID 19492242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anaplastic oligodendroglioma after childhood acute lymphoblastic leukemia: chemotherapy and autologous peripheral blood stem cell transplantation.

  2008cited by this paper
• JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway.

  2008influential reference
• Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.

  2008cited by this paper
• Epithelioid trophoblastic tumor of paracervix and parametrium

  2007cited by this paper
• Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells.

  2007cited by this paper
• The Cancer Chemotherapy Drug Etoposide (VP-16) Induces Proinflammatory Cytokine Production and Sickness Behavior–like Symptoms in a Mouse Model of Cancer Chemotherapy–Related Symptoms

  2006cited by this paper
• Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase.

  2006cited by this paper
• Establishment of a multidrug resistant cell line JAR/VP16 of human choriocarcinoma and analyses of the expression of multidrug resistance-and apoptosis-associated genes

  2006cited by this paper
• JWA IS REQUIRED FOR THE ANTIPROLIFERATIVE AND PRO‐APOPTOTIC EFFECTS OF ALL‐TRANS RETINOIC ACID IN HELA CELLS

  2006cited by this paper
• p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposide

  2005cited by this paper
• JNK Regulates the Release of Proapoptotic Mitochondrial Factors in Reovirus-Infected Cells

  2004cited by this paper
• A Role for P-Glycoprotein in Environmental Toxicology

  2003cited by this paper
• P-glycoprotein: from genomics to mechanism

  2003cited by this paper
• Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

  2003cited by this paper
• The role of MAPK pathways in the action of chemotherapeutic drugs.

  2002cited by this paper
• Caspase activation in etoposide‐treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells.

  2002cited by this paper
• MEK6 regulates human involucrin gene expression via a p38alpha - and p38delta -dependent mechanism.

  2001cited by this paper
• Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation.

  2001cited by this paper
• The mitochondrial permeability transition initiates autophagy in rat hepatocytes

  2001cited by this paper
• MEK6 Regulates Human Involucrin Gene Expression via a p38α- and p38δ-dependent Mechanism

  2001cited by this paper
• An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.

  2001cited by this paper
• Down-regulation of Intrinsic P-glycoprotein Expression in Multicellular Prostate Tumor Spheroids by Reactive Oxygen Species*

  2001cited by this paper
• Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.

  2000cited by this paper
• Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.

  2000cited by this paper
• Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide.

  2000cited by this paper
• Drug resistance factors in acute myeloid leukemia: a comparative analysis

  2000cited by this paper
• Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death*

  1999cited by this paper
• MKK6 Activates Myocardial Cell NF-κB and Inhibits Apoptosis in a p38 Mitogen-activated Protein Kinase-dependent Manner*

  1998cited by this paper
• Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein Kinase*

  1998cited by this paper
• Apoptosis: potential for disease therapies.

  1998cited by this paper
• Apoptosis, cancer and cancer therapy.

  1997cited by this paper
• Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.

  1994cited by this paper
• Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.

  1993cited by this paper
• Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

  1993cited by this paper
• Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain.

  1992cited by this paper

• Unraveling the Mechanism of Curculiginis Rhizoma in Suppressing Cisplatin Resistance in Non-Small Cell Lung Cancer: An Experimental Study

  2024cites this paper
• Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery

  2022cites this paper
• Acridone and its Analogues Emphasizing as Anticancer Agents

  2019cites this paper
• JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells

  2017cites this paper
• Reversal effects of local anesthetics on P-glycoprotein-mediated cancer multidrug resistance

  2017cites this paper
• Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?

  2016cites this paper
• Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.

  2015cites this paper
• Galloyl benzamide‐based compounds modulating tumour necrosis factor α‐stimulated c‐Jun N‐terminal kinase and p38 mitogen‐activated protein kinase signalling pathways

  2015cites this paper
• EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells

  2015cites this paper
• JWA regulates human esophageal squamous cell carcinoma and human esophageal cells through different mitogen-activated protein kinase signaling pathways

  2014cites this paper
• JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells

  2014cites this paper
• Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells

  2012cites this paper
• COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.

  2011cites this paper